Literature DB >> 25829284

Kinases: a remote control in inflammasome activity.

Alexander Czachor1, Young Cho1, Richard F Lockey1, Narasaiah Kolliputi2.   

Abstract

Keywords:  ASC; Inflammasome; Kinase

Year:  2015        PMID： 25829284      PMCID： PMC4580689          DOI： 10.1007/s12079-015-0287-5

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN： 1873-9601            Impact factor:   5.782


× No keyword cloud information.
  13 in total

1.  Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome.

Authors:  Mirjam Kool; Virginie Pétrilli; Thibaut De Smedt; Aline Rolaz; Hamida Hammad; Menno van Nimwegen; Ingrid M Bergen; Rosa Castillo; Bart N Lambrecht; Jürg Tschopp
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

Review 2.  Deregulated inflammasome signaling in disease.

Authors:  Mohamed Lamkanfi; Lieselotte Vande Walle; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

3.  The inflammasome mediates hyperoxia-induced alveolar cell permeability.

Authors:  Narasaiah Kolliputi; Rahamthulla S Shaik; Aaron B Waxman
Journal:  J Immunol       Date:  2010-04-07       Impact factor: 5.422

4.  Methylsulfonylmethane inhibits NLRP3 inflammasome activation.

Authors:  Huijeong Ahn; Jeeyoung Kim; Min-Jae Lee; Young Jin Kim; Young-Wook Cho; Geun-Shik Lee
Journal:  Cytokine       Date:  2014-11-21       Impact factor: 3.861

Review 5.  The regulation of protein phosphorylation.

Authors:  Louise N Johnson
Journal:  Biochem Soc Trans       Date:  2009-08       Impact factor: 5.407

6.  MicroRNA-200c inhibits apoptosis in pituitary adenoma cells by targeting the PTEN/Akt signaling pathway.

Authors:  Chuangxin Liao; Wenli Chen; Xiang Fan; Xiaobing Jiang; Lubing Qiu; Chunhua Chen; Yonghong Zhu; Haijun Wang
Journal:  Oncol Res       Date:  2013       Impact factor: 5.574

Review 7.  New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease.

Authors:  Dominic De Nardo; Christine M De Nardo; Eicke Latz
Journal:  Am J Pathol       Date:  2013-10-30       Impact factor: 4.307

8.  The active metabolite of spleen tyrosine kinase inhibitor fostamatinib abrogates the CD4⁺ T cell-priming capacity of dendritic cells.

Authors:  Andrew M Platt; Robert A Benson; Ross McQueenie; John P Butcher; Martin Braddock; James M Brewer; Iain B McInnes; Paul Garside
Journal:  Rheumatology (Oxford)       Date:  2014-07-26       Impact factor: 7.580

9.  NLRP3 and downstream cytokine expression elevated in the monocytes of patients with coronary artery disease.

Authors:  Lili Wang; Peng Qu; Jian Zhao; Yeting Chang
Journal:  Arch Med Sci       Date:  2014-08-29       Impact factor: 3.318

10.  Mitochondrial ROS potentiates indirect activation of the AIM2 inflammasome.

Authors:  Deborah D Crane; Timothy J Bauler; Tara D Wehrly; Catharine M Bosio
Journal:  Front Microbiol       Date:  2014-08-20       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.